Authors:
Josting, A
Reiser, M
Wickramanayake, PD
Rueffer, U
Draube, A
Sohngen, D
Tesch, H
Wolf, J
Diehl, V
Engert, A
Citation: A. Josting et al., Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (Dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue - A highly effective regimen for patients with refractory or relapsed indolent lymphoma, LEUK LYMPH, 37(1-2), 2000, pp. 115-123
Authors:
Josting, A
Reiser, M
Wickramanayake, PD
Rueffer, U
Draube, A
Sohngen, D
Tesch, H
Wolf, J
Diehl, V
Engert, A
Citation: A. Josting et al., Dexa-BEAM: An effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphoma, LEUK LYMPH, 37(1-2), 2000, pp. 185-187
Authors:
Mantovani, L
Lentini, C
Hentschel, B
Wickramanayake, PD
Loeffler, M
Diehl, V
Tesch, H
Citation: L. Mantovani et al., Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin, BR J HAEM, 109(2), 2000, pp. 367-375
Authors:
Reiser, M
Josting, A
Wickramanayake, PD
Draube, A
Scheid, C
Tesch, H
Wolf, J
Diehl, V
Engert, A
Citation: M. Reiser et al., Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphoma, LEUK LYMPH, 33(3-4), 1999, pp. 305-312
Authors:
Steinmetz, HT
Schulz, A
Staib, P
Scheid, C
Glasmacher, A
Neufang, A
Franklin, J
Tesch, H
Diehl, V
Wickramanayake, PD
Citation: Ht. Steinmetz et al., Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML, ANN HEMATOL, 78(9), 1999, pp. 418-425
Authors:
Scheid, C
Draube, A
Reiser, M
Schulz, A
Chemnitz, J
Nelles, S
Fuchs, M
Winter, S
Wickramanayake, PD
Diehl, V
Sohngen, D
Citation: C. Scheid et al., Using at least 5x10(6)/kg CD34(+) cells for autologous stern cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation, BONE MAR TR, 23(11), 1999, pp. 1177-1181